Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?
Monica Fung(University of California, San Francisco), Jennifer M. Babik(University of California, San Francisco), Peter Chin‐Hong(University of California, San Francisco), Aaron C. Logan(University of California, San Francisco), Larissa Graff(University of California, San Francisco), Sarah B. Doernberg(Johns Hopkins University), Mimi Lo(University of California, San Francisco), Charles Langelier(University of California, San Francisco), Marisela Tan(University of California, San Francisco), Brian S. Schwartz(University of California, San Francisco)
Cited by 63
Related Papers
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
|Clinical Infectious Diseases|2012|299
FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences
|Nucleic Acids Research|2019|268